[The modulatory role of endocannabinoids in sleep].

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Revista de neurología (Ed. impresa)

• Publication date

  2008-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.33588/RN.4603.2006616PMID 18297624
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Localization of N‐acyl phosphatidylethanolamine phospholipase D (NAPE‐PLD) expression in mouse brain: A new perspective on N‐acylethanolamines as neural signaling molecules

  2008cited by this paper
• GPR55: a new member of the cannabinoid receptor clan?

  2007cited by this paper
• Diurnal variation of arachidonoylethanolamine, palmitoylethanolamide and oleoylethanolamide in the brain of the rat.

  2006cited by this paper
• Discovery of the Presence and Functional Expression of Cannabinoid CB2 Receptors in Brain

  2006cited by this paper
• Cannabinoid CB2 receptors: immunohistochemical localization in rat brain.

  2006cited by this paper
• Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats

  2006cited by this paper
• The endocannabinoid system: physiology and pharmacology.

  2005cited by this paper
• Marijuana Use and Its Association With Adherence to Antiretroviral Therapy Among HIV-Infected Persons With Moderate to Severe Nausea

  2005cited by this paper
• Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons.

  2004cited by this paper
• Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D.

  2004cited by this paper
• The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.

  2004cited by this paper
• Role of the endocannabinoid system in Alzheimer's disease: new perspectives.

  2004cited by this paper
• Effect of Δ-9-Tetrahydrocannabinol and Cannabidiol on Nocturnal Sleep and Early-Morning Behavior in Young Adults

  2004cited by this paper
• Excitatory and depressant effects of Δ9-tetrahydrocannabinol and cannabidiol on cortical evoked responses in the conscious rat

  2004cited by this paper
• Mechanisms underlying cannabinoid inhibition of presynaptic Ca2+ influx at parallel fibre synapses of the rat cerebellum

  2004cited by this paper
• Sleep modulates cannabinoid receptor 1 expression in the pons of rats.

  2003cited by this paper
• Anandamide enhances extracellular levels of adenosine and induces sleep: an in vivo microdialysis study.

  2003cited by this paper
• Anandamide hydrolysis: a new target for anti-anxiety drugs?

  2003cited by this paper
• Functional consequences of the repeated administration of Delta9-tetrahydrocannabinol in the rat.

  2003cited by this paper
• Functional mapping of cannabinoid receptor homologs in mammals, other vertebrates, and invertebrates.

  2003cited by this paper
• Potential role of the cannabinoid receptor CB1 in rapid eye movement sleep rebound.

  2003cited by this paper
• Cannabis and the brain.

  2003cited by this paper
• Activation of the cannabinoid receptor type 1 decreases glutamatergic and GABAergic synaptic transmission in the lateral amygdala of the mouse.

  2003cited by this paper
• Activation of phosphoinositide 3-kinase/PKB pathway by CB(1) and CB(2) cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction.

  2003cited by this paper
• Pre- and postsynaptic localizations of the CB1 cannabinoid receptor in the dorsal horn of the rat spinal cord.

  2002cited by this paper
• Endocannabinoid hydrolases.

  2002cited by this paper
• Brain monoglyceride lipase participating in endocannabinoid inactivation

  2002cited by this paper
• Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.

  2002cited by this paper
• Cloning and molecular characterization of the rat CB2 cannabinoid receptor.

  2002cited by this paper
• Modulation of cannabinoid agonist binding by 5‐HT in the rat cerebellum

  2002cited by this paper
• Observational analysis of feeding induced by Delta9-THC and anandamide.

  2002cited by this paper
• Cannabinoids and brain injury: therapeutic implications.

  2002cited by this paper
• An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors

  2002cited by this paper
• 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor

  2001cited by this paper
• CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum.

  2001cited by this paper
• The endocannabinoid nervous system: unique opportunities for therapeutic intervention.

  2001cited by this paper
• Therapeutic aspects of cannabis and cannabinoids

  2001cited by this paper
• Anandamide-induced sleep is blocked by SR141716A, a CB1 receptor antagonist and by U73122, a phospholipase C inhibitor

  2001cited by this paper
• GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus.

  2000cited by this paper
• Localization of the CB1 cannabinoid receptor in the rat brain. An immunohistochemical study.

  2000cited by this paper
• Precipitated and spontaneous withdrawal in rats tolerant to anandamide

  2000cited by this paper
• 2-Arachidonoylglycerol and the cannabinoid receptors.

  2000cited by this paper
• Activational role of cannabinoids on movement.

  2000cited by this paper
• Cannabinoid CB(1) receptor agonists increase rat cortical and hippocampal acetylcholine release in vivo.

  2000cited by this paper
• Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol.

  2000cited by this paper
• Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors.

  1999cited by this paper
• Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors

  1999cited by this paper
• Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors

  1999cited by this paper
• Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function.

  1999cited by this paper
• The effects of cannabinoids on the brain.

  1999cited by this paper
• Arachidonylethanolamide (AEA) activation of FOS proto-oncogene protein immunoreactivity in the rat brain.

  1998cited by this paper
• The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by Δ9-tetrahydrocannabinol or anandamide

  1998cited by this paper
• Control of pain initiation by endogenous cannabinoids

  1998cited by this paper
• Adverse effects of cannabis.

  1998cited by this paper
• Anandamide modulates sleep and memory in rats.

  1998cited by this paper
• Cannabinoid Receptors and Their Endogenous Agonist, Anandamide

  1998cited by this paper
• A comparison of delta 9-THC and anandamide induced c-fos expression in the rat forebrain.

  1998cited by this paper
• Dual Effects of Anandamide on NMDA Receptor‐Mediated Responses and Neurotransmission

  1998cited by this paper
• Hippocampal neurotoxicity of Delta9-tetrahydrocannabinol.

  1998cited by this paper
• Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptor.

  1998cited by this paper
• Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons.

  1997cited by this paper
• Occurrence and Biosynthesis of Endogenous Cannabinoid Precursor,N-Arachidonoyl Phosphatidylethanolamine, in Rat Brain

  1997cited by this paper
• Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain.

  1997cited by this paper
• Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat

  1996cited by this paper
• Physiological and behavioural effects of the endogenous cannabinoid, arachidonylethanolamide (anandamide), in the rat

  1996cited by this paper
• Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons.

  1995cited by this paper
• Effect of delta 9-tetrahydrocannabinol on short-term memory in the rat.

  1995cited by this paper
• Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor

  1995cited by this paper
• Discriminative stimulus effects of anandamide in rats.

  1995cited by this paper
• The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide

  1995cited by this paper
• Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist.

  1995cited by this paper
• Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes

  1995cited by this paper
• Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.

  1995cited by this paper
• Formation and inactivation of endogenous cannabinoid anandamide in central neurons

  1994cited by this paper
• The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.

  1994cited by this paper
• Molecular characterization of a peripheral receptor for cannabinoids

  1993cited by this paper
• Loss of cannabinoid receptors in the substantia nigra in Huntington's disease.

  1993cited by this paper
• Early medical use of cannabis

  1993cited by this paper
• Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent.

  1993cited by this paper
• Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells.

  1993cited by this paper
• Isolation and structure of a brain constituent that binds to the cannabinoid receptor.

  1992cited by this paper
• Structure of a cannabinoid receptor and functional expression of the cloned cDNA

  1990cited by this paper
• Cannabinoid receptor localization in brain.

  1990cited by this paper
• Morphometric studies of the rat hippocampus following chronic delta-9-tetrahydrocannabinol (THC).

  1987cited by this paper
• Cellular effects of cannabinoids.

  1986cited by this paper
• Health aspects of cannabis.

  1986cited by this paper
• The effect of chronically administered delta-9-tetrahydrocannabinol upon the polygraphically monitored sleep of normal volunteers.

  1982cited by this paper
• Effects of acute delta 9-THC administration on EEG and EEG power spectra in the rat.

  1982cited by this paper
• Effeets of marijuana extract and tetrahydrocannabinol on electroencephalographic sleep patterns

  1976cited by this paper
• Effects of high dosage delta‐9‐tetrahydrocannabinol on sleep patterns in man

  1975cited by this paper
• Electroencephalographic study of the effects of tetrahydrocannabinols on sleep in the rat.

  1973cited by this paper
• Intravenous Injection in Man of Δ9-Tetrahydrocannabinol and 11-OH-Δ9-Tetrahydrocannabinol

  1972cited by this paper
• Delta‐9‐tetrahydrocannabinol and synhexl: Effects on human sleep patterns

  1972cited by this paper

• Neurochemistry and Pharmacology of Sleep

  2019cites this paper
• Novel object recognition memory in REM sleep-deprived rats: role of the cannabinoid CB1 receptor.

  2019cites this paper
• Role of Orexin on Sleep: Interactions with Other Neurotransmitter Systems

  2015cites this paper
• Yerba Mate: efectos sobre la vigilia y el sueño

  2014cites this paper
• Activation of STAT3 is involved in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptors in rats.

  2013cites this paper
• Waking-promoting action of Yerba Mate (Ilex paraguariensis)

  2013cites this paper
• [Sleep disorders associated with treatment with rimonabant].

  2008cites this paper